Related Experiment Video
Updated: Jul 5, 2026

Zinc-finger Nuclease Enhanced Gene Targeting in Human Embryonic Stem Cells
Published on: August 23, 2014
Guilt by association: PAX3-FOXO1 regulates gene expression through selective destabilization of the EGR1
Wendy Roeb1, Antonia Boyer, Webster K Cavenee
1The Ludwig Institute for Cancer Research, University of California at San Diego, La Jolla, California, USA.
Abstract:
Human cancer cells frequently harbor chromosomal translocations that create chimeric fusion genes. The t(2;13) translocation is characteristic of the pediatric muscle tumor, alveolar rhabdomyosarcoma, and produces the chimeric transcription factor, PAX3-FOXO1, that contains the DNA binding elements of PAX3 and the transcriptional activation domain of FOXO1. Experiments designed to determine how PAX3-FOXO1 expression contributes to the development of muscle cell-derived tumors resulted in the discovery that the fusion protein misregulates gene expression and interrupts myogenic differentiation through a unique gain of function mechanism. These results yield new insight into how tumor-associated genetic alterations increase the likelihood of cancer formation and may lead to new therapeutic approaches.
Insights
The t(2;13) translocation creates the PAX3-FOXO1 fusion protein in alveolar rhabdomyosarcoma. This protein disrupts muscle cell development through a novel gain-of-function mechanism, offering new therapeutic insights for pediatric cancers.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Chromosomal translocations are common in human cancers, leading to chimeric fusion genes.
- The t(2;13) translocation is a hallmark of alveolar rhabdomyosarcoma, a pediatric muscle tumor.
- This translocation produces the PAX3-FOXO1 fusion protein, combining PAX3 DNA-binding and FOXO1 activation domains.
Purpose of the Study:
- To investigate how PAX3-FOXO1 expression drives the development of muscle-derived tumors.
- To elucidate the molecular mechanisms underlying PAX3-FOXO1-mediated tumorigenesis.
Main Methods:
- Analysis of gene expression in tumor cells.
- Functional studies to assess the impact of PAX3-FOXO1 on myogenic differentiation.
Main Results:
- PAX3-FOXO1 expression was found to misregulate target gene expression.
- The fusion protein was shown to interrupt normal myogenic differentiation.
- A unique gain-of-function mechanism was identified as responsible for these effects.
Conclusions:
- PAX3-FOXO1 drives rhabdomyosarcoma development through aberrant gene regulation and impaired differentiation.
- Understanding this gain-of-function mechanism provides insight into cancer formation.
- These findings may pave the way for novel therapeutic strategies targeting PAX3-FOXO1.
Related Concept Videos
Combinatorial Gene Control
The expression of more than 30,000 genes is controlled by approximately 2000-3000 transcription factors. This is possible because a single transcription factor can recognize more than one regulatory sequence. The specificity in gene...
Master Transcription Regulators
Abnormal Proliferation
Regulation of Expression Occurs at Multiple Steps
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
Regulation of Expression Occurs at Multiple Steps
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
RNA Polymerase II Accessory Proteins

